You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 296 No. 11, September 20, 2006 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Research Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (11)
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Similar articles in JAMA
 Topic Collections
 •Aging/ Geriatrics
 •Women's Health
 •Women's Health, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

High-Sensitivity C-Reactive Protein and Fracture Risk in Elderly Women

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Reduced bone mass and increased risk of fracture have been associated with inflammatory diseases such as rheumatoid arthritis,1 inflammatory bowel disease,2 and ankylosing spondylitis.3 Inflammatory cytokines stimulate osteoclastic bone resorption4 and inhibit osteoblast function.5 We hypothesized that serum high-sensitivity C-reactive protein (hsCRP), a marker of systemic inflammation, is associated with fracture risk.

Methods

An age-stratified sample of 1494 women (99% white), representing 77.1% of eligible participants, was randomly recruited from electoral rolls for the Geelong Osteoporosis Study.6 The study region is characteristic of Australia in age distribution and socioeconomic indicators. The inclusion criterion of age 65 years or older was met by 522 women. Of these, 33 were excluded because serum was unavailable for analysis and 45 were excluded for baseline use of hormone therapy or oral glucocorticoids for at least 6 months, leaving a study population of 444 women. Participants were comparable with those excluded except that . . . [Full Text of this Article]

Julie A. Pasco, PhD
juliep@barwonhealth.org.au

Mark A. Kotowicz, MBBS, FRACP; Margaret J. Henry, PhD; Geoffrey C. Nicholson, PhD, FRCP, FRACP
Department of Clinical and Biomedical Sciences: Barwon Health
University of Melbourne
Geelong, Australia

Heather J. Spilsbury, MSc; Jeffrey D. Box, PhD
Alfred Pathology Service
Melbourne, Australia

Hans G. Schneider, MD, FRACP, FRCPA
Department of Medicine
Monash University
Melbourne, Australia



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTER

High-Sensitivity C-Reactive Protein and Prediction of Nontraumatic Fractures—Reply
Georg Schett and Stefan Kiechl
Arch Intern Med. 2007;167(18):2007-2008.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Interleukin-1 is essential for systemic inflammatory bone loss
Polzer et al.
Ann Rheum Dis 2010;69:284-290.
ABSTRACT | FULL TEXT  

Circulating Levels of Inflammatory Markers Predict Change in Bone Mineral Density and Resorption in Older Adults: A Longitudinal Study
Ding et al.
J. Clin. Endocrinol. Metab. 2008;93:1952-1958.
ABSTRACT | FULL TEXT  

High-Sensitivity C-Reactive Protein and Prediction of Nontraumatic Fractures Reply
Schett and Kiechl
Arch Intern Med 2007;167:2007-2008.
FULL TEXT  

What's new in the other general journals
Tonks
BMJ 2006;333:699-700.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.